Hazlett, Burt & Watson’s DexCom DXCM Stock Holding History

Hazlett, Burt & Watson’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7K	Hold	100	–	–	﹤0.01%	732
2026 Q1	$6K	Hold	100	–	–	﹤0.01%	757
2025 Q4	$7K	Hold	100	–	–	﹤0.01%	748
2025 Q3	$7K	Hold	100	–	–	﹤0.01%	699
2025 Q2	$9K	Hold	100	–	–	﹤0.01%	599
2025 Q1	$7K	Sell	100 -17	-15%	-$1.39K	﹤0.01%	619
2024 Q4	$9K	Sell	117 -10	-8%	-$740	﹤0.01%	556
2024 Q3	$9K	Hold	127	–	–	﹤0.01%	542
2024 Q2	$14K	Hold	127	–	–	0.01%	486
2024 Q1	$17K	Hold	127	–	–	0.01%	455
2023 Q4	$15K	Hold	127	–	–	0.01%	450
2023 Q3	$12K	Buy	127 +10	+9%	+$1.13K	0.01%	476
2023 Q2	$15K	Buy	117 +17	+17%	+$2.06K	0.01%	438
2023 Q1	$12K	Hold	100	–	–	0.01%	430
2022 Q4	$11K	Hold	100	–	–	0.01%	446
2022 Q3	$8K	Hold	100	–	–	0.01%	472
2022 Q2	$7K	Hold	100	–	–	0.01%	479
2022 Q1	$13K	Buy	+100	New	+$10.9K	0.01%	444

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Hazlett, Burt & Watson's DXCM Position: Q2 2026 in Review

Hazlett, Burt & Watson held its DexCom (DXCM) position steady in Q2 2026 at 100 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #732.

Hazlett, Burt & Watson first reported a position in DXCM in Q1 2022 and has held it in 18 quarters since. The position peaked at $17K in Q1 2024. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Hazlett, Burt & Watson held 100 shares of DexCom worth $7K as of Q2 2026.
Hazlett, Burt & Watson left its DexCom share count unchanged in Q2 2026.
DexCom made up ﹤0.01% of Hazlett, Burt & Watson's portfolio in Q2 2026, its #732 holding.
Hazlett, Burt & Watson first reported a position in DexCom in Q1 2022 and has held it in 18 quarters since.
Hazlett, Burt & Watson's DexCom position peaked at $17K in Q1 2024.
973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q2 2026, filed 30 Jul 2026.